Cargando…
The affinity of antigen-binding domain on the antitumor efficacy of CAR T cells: Moderate is better
The overall efficacy of chimeric antigen receptor modified T cells (CARTs) remain limited in solid tumors despite intensive studies that aim at targeting multiple antigens, enhancing migration, reducing tonic signaling, and improving tumor microenvironment. On the other hand, how the affinity and en...
Autores principales: | Mao, Rui, Kong, Wanqing, He, Yukai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618871/ https://www.ncbi.nlm.nih.gov/pubmed/36325345 http://dx.doi.org/10.3389/fimmu.2022.1032403 |
Ejemplares similares
-
TCR T cells overexpressing c-Jun have better functionality with improved tumor infiltration and persistence in hepatocellular carcinoma
por: Hussein, Mohamed S., et al.
Publicado: (2023) -
IL-15 armoring enhances the antitumor efficacy of claudin 18.2-targeting CAR-T cells in syngeneic mouse tumor models
por: Shi, Hongtai, et al.
Publicado: (2023) -
A promising antitumor method: Targeting CSC with immune cells modified with CAR
por: Huang, Binjie, et al.
Publicado: (2022) -
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells
por: Liu, Enli, et al.
Publicado: (2021) -
Switch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells
por: Zhao, Songbo, et al.
Publicado: (2021)